Document is current
Any future updates will be listed below
-
Authors
Theruvath, Johanna
Sotillo, Elena
Mount, Christopher W.
Graef, Claus Moritz
Delaidelli, Alberto
Heitzeneder, Sabine
Labanieh, Louai
Dhingra, Shaurya
Leruste, Amaury
Majzner, Robbie G.
Xu, Peng
Mueller, Sabine
Yecies, Derek W. https://orcid.org/0000-0001-8534-4651
Finetti, Martina A. https://orcid.org/0000-0001-8173-1646
Williamson, Daniel
Johann, Pascal D.
Kool, Marcel
Pfister, Stefan
Hasselblatt, Martin
Frühwald, Michael C.
Delattre, Olivier
Surdez, Didier https://orcid.org/0000-0002-7118-7859
Bourdeaut, Franck
Puget, Stephanie
Zaidi, Sakina https://orcid.org/0000-0001-9128-0287
Mitra, Siddhartha S. https://orcid.org/0000-0002-1829-7856
Cheshier, Samuel
Sorensen, Poul H.
Monje, Michelle https://orcid.org/0000-0002-3547-237X
Mackall, Crystal L. https://orcid.org/0000-0001-6323-4304
- License Information
-
More Information
Article History
Received: 11 July 2019
Accepted: 6 March 2020
First Online: 27 April 2020
Competing interests
: R.G.M., L.L. and E.S. hold several patent applications in the area of CAR T cell immunotherapy. C.L.M. is an inventor on a patent application for B7-H3 CAR T cells and holds several patent applications in the area of CAR T cell immunotherapy. C.L.M. is a founder of, holds equity in and receives consulting fees from Lyell Immunopharma. C.L.M. has also received consulting fees from NeoImmune Tech, Nektar Therapeutics and Apricity Health and royalties from Juno Therapeutics for the CD22-CAR. R.G.M, E.S. and L.L. are consultants for Lyell Immunopharma. R.G.M. is a consultant for Xyphos, Illumina Radiopharmaceuticals, GammaDelta Therapeutics and PACT Pharma. J.T. is a consultant for Dorian Therapeutics.
